Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer - Papachristofilou, Alexandros; Sebastian, Martin; Bischoff, Helge (BioMed Central, 2019)
In: Journal for ImmunoTherapy of Cancer, 7 (2019), Nr. 38. pp. 1-14. ISSN 2051-1426